April 15, 2021
A key health ministry advisory panel will review Bayer Yakuhin’s soluble guanylate cyclase (sGC) stimulator vericiguat for the treatment of chronic heart failure on April 28, two months after putting its decision on hold on whether to recommend its approval...read more